Hiroshi Tobita

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Generalizability of the MetALD-ALD Prediction Index in Asian Populations.

Generalizability of the MetALD-ALD Prediction Index in Asian Populations.

Journal: Gastroenterology

Published: April 24, 2026

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 30, 2026

Acute Hepatitis E virus Subtype 3e Infection with Prolonged Jaundice Improved with Inchinkoto.

Acute Hepatitis E virus Subtype 3e Infection with Prolonged Jaundice Improved with Inchinkoto.

Journal: Internal medicine (Tokyo, Japan)

Published: May 28, 2025

Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S.

Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S.

Journal: Gastro hep advances

Published: January 29, 2025

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L.

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L.

Journal: Diagnostics (Basel, Switzerland)

Published: January 27, 2025

Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis.

Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis.

Journal: Journal of gastroenterology

Published: January 22, 2025

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Journal: BMJ open

Published: November 24, 2024

Changes in Hepatic Density Due to Oral Amiodarone-induced Liver injury Shown by Computed Tomography.

Changes in Hepatic Density Due to Oral Amiodarone-induced Liver injury Shown by Computed Tomography.

Journal: Internal medicine (Tokyo, Japan)

Published: November 20, 2024

Identification of miRNAs associated with eosinophilic esophagitis shown by esophageal mucosal biopsy results of Japanese patients.

Identification of miRNAs associated with eosinophilic esophagitis shown by esophageal mucosal biopsy results of Japanese patients.

Journal: Journal of clinical biochemistry and nutrition

Published: October 31, 2024

Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup Participants.

Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup Participants.

Journal: Gastro hep advances

Published: July 03, 2024

Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan.

Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan.

Journal: Alimentary pharmacology & therapeutics

Published: December 30, 2023

Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.

Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 29, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026